奈米醫學市場按載體類型、應用、分銷管道和地區分類

Nanopharmaceuticals Market, By Carrier Type, By Application, By Distribution Channel, By Geography

出版日期: 2026年01月27日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

奈米醫藥市場預計在 2026 年達到 1,890 億美元，預計到 2033 年將達到 7,620 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 22.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1890億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
預測期（2026-2033 年）複合年成長率：	22.10%	2033 年的預測值：	7620億美元

奈米藥物是粒徑小於1微米的新型藥物，其作用機制基於奈米技術。奈米藥物廣泛應用於藥物遞送，既可作為治療化合物的載體，也可本身作為治療化合物。奈米藥物的設計目標是針對特定的細胞、組織或器官。

市場動態

心血管疾病、癌症和感染疾病的日益普及是推動奈米藥物市場成長的主要因素。根據世界衛生組織（世衛組織）2018年9月發布的情況說明書，2017年全球估計有1,000萬例結核病病例和160萬例死亡病例。此外，奈米藥物相對於傳統藥物的優勢預計也將推動市場成長。奈米藥物可以穿過血腦障壁，到達大腦的遠端區域。此外，透過提高化合物的低溶解度，可以進一步增強其性能。

本次調查的主要特點

本報告對奈米醫學市場進行了詳細分析，並以 2017 年為基準年，給出了預測期（2018-2026 年）的市場規模和複合年成長率。
它還重點介紹了各個細分市場的潛在商機，並解釋了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業的競爭策略的重要見解。
該報告根據公司概況、財務表現、產品系列、市場佔有率、分銷策略、關鍵發展、策略和未來計劃等參數，對全球奈米醫學市場的主要參與者進行了分析。
本報告的研究結果將使負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球奈米醫學市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析奈米醫學市場的策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太地區的其他國家
中東
- GCC
- 以色列
- 其他中東地區
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

熱圖分析
公司簡介
- Abbott Laboratories
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Astrazeneca plc.
- Novavax, Inc.
- Stryker Corporation
- OSI Pharmaceuticals
- Kadmon Pharmaceuticals
- Samyang Biopharm
- Mitsubishi Tanabe Pharma Corporation
- Kaken Pharmaceutical
- Selecta Biosciences
- Par Pharmaceutical
- Cerulean Pharma Inc.
- Navidea Biopharmaceuticals
- AbbVie Inc.
- AMAG Pharmaceuticals
- Amgen Inc.
- Astellas Pharma Inc.
- Celgene Corporation
- Gilead Sciences, Inc.
- JOHNSON &JOHNSON
- Merck &Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Hoffmann-La Roche AG
- Sanofi SA
- Shire Plc.
- Teva Pharmaceuticals Industries Limited.

第9章各節

參考
調查方法

簡介目錄

Product Code: CMI2485

Nanopharmaceuticals Market is estimated to be valued at USD 1,89,000 Mn in 2026 and is expected to reach USD 7,62,000 Mn by 2033, growing at a compound annual growth rate (CAGR) of 22.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,89,000 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	22.10%	2033 Value Projection:	USD 7,62,000 Mn

Nanopharmaceuticals are novel medicine with particle size less than 1 micron, which work on the principle of nanotechnology. Nanopharmaceuticals are widely used in drug delivery as a carrier for therapeutic compound or as a therapeutic compound. Nanopharmaceuticals are designed to target particular cells, tissue or a specific organ.

Market Dynamics

Increasing prevalence of cardiovascular diseases, cancer, and infectious diseases are major factors driving nanopharmaceuticals market growth. The World Health Organization, factsheet September 2018, estimated around 10 million cases of tuberculosis and around 1.6 million deaths from the disease in 2017. Moreover, advantages of nanopharmaceuticals over macroscopic level medicines is expected to boost the market growth. Nanopharmaceuticals can pass the blood brain barrier and can access the remote areas of brain as well as low solubility of the compound can be developed for enhancing its characteristics.

Key features of the study

This report provides in-depth analysis of the nanopharmaceuticals market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global nanopharmaceuticals market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott, GlaxoSmithKline and plc., Eli Lilly and Company, Astrazeneca plc., Novavax, Inc., Stryker Corporation, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Tanabe Pharma Corporation, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma Inc., Navidea Biopharmaceuticals, Inc., AbbVie Inc., AMAG Pharmaceuticals, Amgen Inc., Astellas Pharma Inc., Celgene Corporation, Gilead Sciences, Inc., JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global nanopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the nanopharmaceuticals market

Market Segmentation

By Carrier Type
- Liposomes
- Polymer
- Nanocrystals
- Inorganic
- Protein
- Others
By Application
- Oncology
- Neurology
- Anti-inflammatory
- Anti-infective
- Cardiovascular
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Abbott
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Astrazeneca plc.
- Novavax, Inc.
- Stryker Corporation
- OSI Pharmaceuticals
- Kadmon Pharmaceuticals
- Samyang Biopharm
- Mitsubishi Tanabe Pharma Corporation
- Kaken Pharmaceutical
- Selecta Biosciences
- Par Pharmaceutical
- Cerulean Pharma Inc.
- Navidea Biopharmaceuticals, Inc.
- AbbVie Inc.
- AMAG Pharmaceuticals
- Amgen Inc.
- Astellas Pharma Inc.
- Celgene Corporation
- Gilead Sciences, Inc.
- JOHNSON & JOHNSON
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Hoffmann-La Roche AG
- Sanofi S.A
- Shire Plc.
- Teva Pharmaceuticals Industries Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Carrier Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends

4. Global Nanopharmaceuticals Market, By Carrier Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Nanocrystals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Inorganic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Protein
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Nanopharmaceuticals Market, By Application, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Anti-inflammatory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Nanopharmaceuticals Market, By Distribution Channel, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Nanopharmaceuticals Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
North America
- Market Size and Forecast, By Carrier Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Carrier Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Carrier Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Carrier Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Carrier Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Carrier Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- Abbott Laboratories
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- GlaxoSmithKline plc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Eli Lilly and Company
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Astrazeneca plc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novavax, Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Stryker Corporation
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- OSI Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Kadmon Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Samyang Biopharm
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Mitsubishi Tanabe Pharma Corporation
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Kaken Pharmaceutical
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Selecta Biosciences
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Par Pharmaceutical
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Cerulean Pharma Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Navidea Biopharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- AbbVie Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- AMAG Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Amgen Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Astellas Pharma Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Celgene Corporation
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Gilead Sciences, Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- JOHNSON & JOHNSON
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novartis AG
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Pfizer, Inc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Hoffmann-La Roche AG
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Sanofi S.A
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Shire Plc.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Teva Pharmaceuticals Industries Limited.
  - Company Overview
  - Product Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views